Editorial for “ IOP Injection, A Novel Superparamagnetic Iron Oxide Particle MRI Contrast Agent for the Detection of Hepatocellular Carcinoma: A Phase II Clinical Trial”
Journal of Magnetic Resonance Imaging · 2023
DOI: 10.1002/jmri.28657 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Magnetic Resonance Imaging, 2023. Verfasst von Jaume Coll-Font und 1 weiteren Autor:innen. Beteiligte Einrichtung: Acutus Medical Inc., Carlsbad, California, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetite Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Acutus Medical Inc., Carlsbad, California, USA.
- Cardiovascular Innovation Research Center, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Jaume Coll-Font, Christopher Nguyen
Zitieren
APA
Coll-Font, J., & Nguyen, C. (2023). Editorial for “ IOP Injection, A Novel Superparamagnetic Iron Oxide Particle MRI Contrast Agent for the Detection of Hepatocellular Carcinoma: A Phase II Clinical Trial”. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.28657
Vancouver
Coll-Font J, Nguyen C. Editorial for “ IOP Injection, A Novel Superparamagnetic Iron Oxide Particle MRI Contrast Agent for the Detection of Hepatocellular Carcinoma: A Phase II Clinical Trial”. Journal of Magnetic Resonance Imaging. 2023. doi:10.1002/jmri.28657
BibTeX
@article{CollFont2023,
author = {Coll-Font, Jaume and Nguyen, Christopher},
title = {Editorial for “ IOP Injection, A Novel Superparamagnetic Iron Oxide Particle MRI Contrast Agent for the Detection of Hepatocellular Carcinoma: A Phase II Clinical Trial”},
journal = {Journal of Magnetic Resonance Imaging},
year = {2023},
doi = {10.1002/jmri.28657}
}
EUVIMED